Identification of a Novel PROP1 Mutation in a Patient with Combined Pituitary Hormone Deficiency and Enlarged Pituitary

Int J Mol Sci. 2019 Apr 16;20(8):1875. doi: 10.3390/ijms20081875.

Abstract

Growth hormone deficiency (GHD) can be present from the neonatal period to adulthood and can be the result of congenital or acquired insults. In addition, GHD can be classified into two types: isolated growth hormone deficiency (IGHD) and combined pituitary hormone deficiency (CPHD). CPHD is a disorder characterized by impaired production of two or more anterior and/or posterior pituitary hormones. Many genes implicated in CPHD remain to be identified. Better genetic characterization will provide more information about the disorder and result in important genetic counselling because a number of patients with hypopituitarism represent familial cases. To date, PROP1 mutations represent the most common known genetic cause of CPHD both in sporadic and familial cases. We report a novel mutation in the PROP1 gene in an infant with CPHD and an enlarged pituitary gland. Close long-term follow-up will reveal other possible hormonal defects and pituitary involution.

Keywords: PROP1; combined pituitary hormone deficiency; growth hormone deficiency; isolated growth hormone deficiency; pituitary gland.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Female
  • Gene Deletion
  • Growth Hormone / therapeutic use
  • Homeodomain Proteins / genetics*
  • Humans
  • Hypopituitarism / diagnosis*
  • Hypopituitarism / drug therapy
  • Hypopituitarism / genetics
  • Magnetic Resonance Imaging
  • Pituitary Gland / diagnostic imaging*
  • Thyroxine / therapeutic use

Substances

  • Homeodomain Proteins
  • Prophet of Pit-1 protein
  • Growth Hormone
  • Thyroxine

Supplementary concepts

  • Combined Pituitary Hormone Deficiency